about
Global expression of molecular transporters in the human vaginal tract: implications for HIV chemoprophylaxisHIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationshipsPharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model.The 30-year war on AIDS: have we reached the tipping point?Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access.Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaquesAn intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates.Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.Operational research to improve HIV prevention in the United States.A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine ModelMucosal immunology of HIV infection.Correctional facilities as partners in reducing HIV disparities.Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.Microbicides: still a long road to successAn intravaginal ring for the simultaneous delivery of multiple drugs.Linker-extended native cyanovirin-N facilitates PEGylation and potently inhibits HIV-1 by targeting the glycan ligand.Discovery of novel anti-HIV agents via Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry-based approach.Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors.Male circumcision for protection against HIV infection in sub-Saharan Africa: the evidence in favour justifies the implementation now in progress.Pharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque Model.Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011.PrEP Implementation Science: State-of-the-Art and Research Agenda.Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery.Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans.
P2860
Q28534412-56D0B0A5-182B-4627-9164-BCE83955C0EAQ28731648-3BBC136D-B39E-4ADA-B464-705AC877C3A7Q34057568-4E8A9465-F6FA-4DD7-BF0B-ACF4B6514D86Q35580656-51AA7D18-BEF3-46A9-B5A5-E3BBAAF4FE83Q35875746-73CAED7B-4072-4FBD-833D-A856646FD8A4Q35941408-CD3E5B0B-45E0-48E7-82AF-768D1C2AF0C7Q36173759-A92C328B-1DED-41AB-B653-6719D209803DQ36292585-377CC5D4-0F5E-413A-A446-4ABC7CEA157CQ36364164-61395C4C-96E6-4BB7-8AAC-863E34C9FBD2Q36365333-2C67FBFE-DEDF-4B03-9D2F-29787D895E84Q36396237-2AEAB240-CD84-4C03-B3B4-DE93E0C0F237Q36933498-5E694AEA-3939-491A-AB71-CF770BBEFA1DQ36957775-A377CBAE-22D2-409C-91F5-04835FFB9317Q36981681-05475720-C9BE-410D-B6FC-20B2DC0398E8Q37069793-0E12BF7B-B931-4A89-8AED-8551928CBE39Q37130757-1ED2E28C-D9FF-4839-9EC3-662AD0705602Q37379716-ACE6D360-6E2F-4C66-A883-AF49DBF7F290Q37520722-76E35BF0-FEEB-41E9-8CE6-CB868257913EQ38843215-E25AB253-60F7-4B96-A850-C88265145A5DQ39382195-3831AED2-D5B8-4380-BBAF-3B5506AFD6B7Q39571729-AFE01019-41E1-4660-AAC4-C57705EFF4B5Q40239519-9EB8E9F1-A6FE-422A-A453-2B8D77619C59Q42411962-940DCAA0-F3E1-4382-9CA3-FB85B0C47970Q43241737-E7D31CEB-63F2-432E-9A66-2ACB4C97D71EQ52579066-1B4253AC-0120-4C42-ACAC-52753EF40710Q52657155-A8F32004-23B7-414D-ACFB-E5BDF58A582B
P2860
description
article publiƩ dans la revue scientifique Science
@fr
im Juni 2011 verƶffentlichter wissenschaftlicher Artikel
@de
scientific article published in Science
@en
wetenschappelijk artikel
@nl
Š½Š°ŃŠŗŠ¾Š²Š° ŃŃŠ°ŃŃŃ, Š¾ŠæŃŠ±Š»ŃŠŗŠ¾Š²Š°Š½Š° Š² ŃŠµŃŠ²Š½Ń 2011
@uk
name
Turning the Tide Against HIV
@en
Turning the Tide Against HIV
@nl
type
label
Turning the Tide Against HIV
@en
Turning the Tide Against HIV
@nl
prefLabel
Turning the Tide Against HIV
@en
Turning the Tide Against HIV
@nl
P2860
P356
P1433
P1476
AIDS. Turning the tide against HIV
@en
P2093
Mitchell Warren
Sheena McCormack
P2860
P356
10.1126/SCIENCE.1206399
P407
P577
2011-07-01T00:00:00Z